- Home
- MREO vs HSDT Comparison
MREO vs HSDT Comparison
Compare MREO & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MREO | HSDT |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | 21 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 98.2M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | MREO | HSDT |
|---|---|---|
| Price | $0.33 | $1.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $1.50 | ★ $4.00 |
| AVG Volume (30 Days) | ★ 1.4M | 337.2K |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $500,000.00 | N/A |
| Revenue This Year | $6,000.20 | N/A |
| Revenue Next Year | $34.71 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.20 | $0.26 |
| 52 Week High | $2.94 | $25.50 |
Technical Indicators
Market Signals| Indicator | MREO | HSDT |
|---|---|---|
| Relative Strength Index (RSI) | 40.25 | 48.85 |
| Support Level | $0.32 | $1.95 |
| Resistance Level | $0.42 | $2.05 |
| Average True Range (ATR) | 0.02 | 0.18 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 29.29 | 60.94 |
Price Performance
Historical ComparisonAbout MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About HSDT Helius Medical Technologies Inc. (DE)
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities. Through this model, Solana Company provides public market investors with efficient and direct exposure to Solana's long-term growth potential.